COMP <GO>
STLN vs SBC // DIVIDEND YIELD & FCF PAYOUT SAFETY
Starling Oncology Inc. (NASDAQ) VS. SBC Medical Group Holdings Incorporated (NASDAQ) • 15-METRIC TALLY: STLN 3
— SBC 6
■ METRIC PARITY
LAST: $6.65 (+0.15%) • MKT CAP: $677.7M
dividend-safety
0.00%
LAST: $5.69 (+4.40%) • MKT CAP: $585.2M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STLN VS. SBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STLN | SBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 73.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 63.10% | -98.10 | SBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.10% | 3.98% | -8.08 | SBC | /fcf-yield <GO> |
| Operating Margin | -7.20% | 38.90% | -46.10 | SBC | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 29.40% | +38.60 | STLN | /net-margins <GO> |
| Revenue Growth (YoY) | 27.80% | -15.50% | +43.30 | STLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.58 | 5.46 | -2.88 | SBC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | SBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.5 | 51.8 | -2.31 | SBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 10.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $677.7M | $585.2M | $92.5M | STLN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STLN REV | SBC REV | STLN GROSS % | SBC GROSS % | STLN FCF | SBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $502.7M | $173.6M | — | 73.3% | -$27.8M | $23.3M |
| FY 2024 | $393.4M | $205.4M | — | 76.0% | -$30.3M | $18.0M |
| FY 2023 | $324.2M | $193.5M | — | — | -$36.3M | $50.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STLN // BETA —
SBC // BETA —